RemeGen Co., Ltd. Announces Phase 3 Clinical Trial of Disitamab Vedotin as First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma Reaches Its Primary Endpoints of PFS and OS
RemeGen Co., Ltd. Announces Phase 3 Clinical Trial of Disitama…
May 12, 2025
marketscreener.com
Disitamab Vedotin: Promising HER2-Targeted Therapy for Urothelial Cancer - Matthew Galsky
Disitamab Vedotin: Promising HER2-Targeted Therapy for Uroth…
Sep 15, 2024
urotoday.com
Disitamab Vedotin: Promising HER2-Targeted Therapy for Urothelial Cancer - Matthew Galsky
Disitamab Vedotin: Promising HER2-Targeted Therapy for Uroth…
Sep 15, 2024
urotoday.com
RemeGen erhält Zulassung für Disitamab-Vedotin
RemeGen erhält Zulassung für Disitamab-Vedotin
1 month ago
marketscreener.com
RC48001: disitamab vedotin in HER2-expressing advanced urothelial cancer
1:10
RC48001: disitamab vedotin in HER2-expressing advanced uroth…
41 views2 months ago
YouTubeVJOncology
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer
Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent …
1 month ago
vumedi.com
Clinical Trials Evaluating Tisotumab Vedotin in Patients with Recurrent or Metastatic Cervical Cancer | OncLive
8:43
Clinical Trials Evaluating Tisotumab Vedotin in Patients with Recurren…
Jan 10, 2024
onclive.com
1:33
RC48-C016: disitamab vedotin & toripalimab vs chemotherapy in H…
122 views7 months ago
YouTubeVJOncology
2:58
Disitamab Vedotin With Pembrolizumab Versus Chemothe…
296 viewsJun 5, 2024
YouTubeGU Oncology Now
2:13
For patients with recurrent cervical cancer, limited treatment options …
969 viewsJul 9, 2024
FacebookThe New England Journal of Medicine
2:16
In high-risk Hodgkin’s lymphoma, brentuximab vedotin in combinati…
1.6K viewsOct 31, 2022
FacebookThe New England Journal of Medicine
Erdafitinib versus enfortumab vedotin in previously treated uroth…
Apr 6, 2021
urologytimes.com
8:23
Disitamab Vedotin Plus Pembrolizumab in aUC: HER2 Stat…
263 viewsSep 18, 2024
YouTubeGU Oncology Now
Genmab A/S: TIVDAK (tisotumab vedotin) Approved by Japan Minis…
Mar 27, 2025
finanznachrichten.de
FDA Approval of Tisotumab Vedotin for Recurrent or Metastatic Cervic…
Nov 1, 2021
onclive.com
1:43
Dr Fujiwara on the FDA Approval of Tisotumab Vedotin for Recurrent …
Apr 29, 2024
onclive.com
2:15
A combination of brentuximab vedotin plus doxorubicin, vinblast…
3.7K viewsJul 27, 2022
FacebookThe New England Journal of Medicine
2:12
Up to 40% of patients receiving the standard R-CHOP regimen for diff…
5.6K viewsJan 27, 2022
FacebookThe New England Journal of Medicine
2:04
Dr Sanborn on Early Efficacy and Safety Data With Sigvotatug Vedot…
9 months ago
onclive.com
ECHELON-1 Trial: Brentuximab Vedotin With Chemotherapy Offer…
Aug 8, 2022
ascopost.com
6:26
HER2-Directed Strategies in Urothelial Cancer
591 views2 months ago
YouTubeOncUpdates: Latest Oncology Insights
1:00
Rash management for Enfortumab Vedotin
791 viewsApr 21, 2024
YouTubeOncBrothers: Practice-Changing Cancer Discus…
1:19
Dr. Smith Discusses Brentuximab Vedotin in CTCL
367 viewsJul 20, 2018
YouTubeOncLive
7:24
Brentuximab Vedotin and Chemotherapy in Classical HL
84 viewsJul 17, 2019
YouTubeTargeted Oncology
0:56
PACIFIC: Brentuximab vedotin in mediastinal DLBCL
186 viewsFeb 2, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
4:47
Disitamab vedotin & neoadjuvant toripalimab for MIBC in the RC48-…
93 viewsFeb 28, 2025
YouTubeVJOncology
1:47
Dr. Hamlin Discusses Integrating Brentuximab Vedotin
827 viewsFeb 10, 2012
YouTubeOncLive
6:13
Brentuximab Vedotin
2.8K viewsSep 14, 2016
YouTubeOncLive
4:59
iMeta | Efficacy vedotin combined immunotherapy in patients with m…
23 viewsApr 29, 2025
YouTubeiMeta Science
2:47
Tisotumab vedotin shows clinically meaningful OS improvement vers…
68 viewsFeb 20, 2024
YouTubeecancer
See more videos
Static thumbnail place holder